Pharming Group N.V. (PHAR) Inventory Average (2020 - 2024)

Pharming (PHAR) has disclosed Inventory Average for 5 consecutive years, with $56.2 million as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Inventory Average rose 105.26% year-over-year to $56.2 million, compared with a TTM value of $56.2 million through Dec 2024, up 105.26%, and an annual FY2024 reading of $56.2 million, up 105.26% over the prior year.
  • Inventory Average was $56.2 million for Q4 2024 at Pharming, up from $27.4 million in the prior quarter.
  • Across five years, Inventory Average topped out at $56.2 million in Q4 2024 and bottomed at -$2.2 million in Q4 2022.
  • Average Inventory Average over 5 years is $21.7 million, with a median of $18.3 million recorded in 2020.
  • The sharpest move saw Inventory Average tumbled 124.47% in 2022, then surged 1339.85% in 2023.
  • Year by year, Inventory Average stood at $18.3 million in 2020, then tumbled by 50.55% to $9.0 million in 2021, then crashed by 124.47% to -$2.2 million in 2022, then soared by 1339.85% to $27.4 million in 2023, then skyrocketed by 105.26% to $56.2 million in 2024.
  • Business Quant data shows Inventory Average for PHAR at $56.2 million in Q4 2024, $27.4 million in Q4 2023, and -$2.2 million in Q4 2022.